{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:10:09Z","timestamp":1770754209714,"version":"3.50.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The South-Eastern Norway Regional Health Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10875-018-0579-7","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T06:30:16Z","timestamp":1545201016000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-4702","authenticated-orcid":false,"given":"Dina M.","family":"Aresvik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torstein","family":"\u00d8verland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf D.","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tore G.","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"579_CR1","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","volume":"1","author":"DM McDonald-McGinn","year":"2015","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071. \n                    https:\/\/doi.org\/10.1038\/nrdp.2015.71\n                    \n                  .","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"579_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/adc.2003.026880","volume":"89","author":"S Oskarsdottir","year":"2004","unstructured":"Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004;89(2):148\u201351.","journal-title":"Arch Dis Child"},{"issue":"8","key":"579_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00431-010-1161-3","volume":"169","author":"K Lima","year":"2010","unstructured":"Lima K, Folling I, Eiklid KL, Natvig S, Abrahamsen TG. Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome. Eur J Pediatr. 2010;169(8):983\u20139. \n                    https:\/\/doi.org\/10.1007\/s00431-010-1161-3\n                    \n                  .","journal-title":"Eur J Pediatr"},{"issue":"1","key":"579_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e3182060469","volume":"90","author":"DM McDonald-McGinn","year":"2011","unstructured":"McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). Medicine (Baltimore). 2011;90(1):1\u201318. \n                    https:\/\/doi.org\/10.1097\/MD.0b013e3182060469\n                    \n                  .","journal-title":"Medicine (Baltimore)"},{"key":"579_CR5","doi-asserted-by":"publisher","unstructured":"Crowley B, Ruffner M, McDonald McGinn DM, Sullivan KE. Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome. Am J Med Genet A. 2018. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.38597\n                    \n                  .","DOI":"10.1002\/ajmg.a.38597"},{"issue":"2","key":"579_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.iac.2008.01.003","volume":"28","author":"KE Sullivan","year":"2008","unstructured":"Sullivan KE. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome\/velocardiofacial syndrome. Immunol Allergy Clin N Am. 2008;28(2):353\u201366. \n                    https:\/\/doi.org\/10.1016\/j.iac.2008.01.003\n                    \n                  .","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"579_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1067\/mpd.2001.118534","volume":"139","author":"AF Jawad","year":"2001","unstructured":"Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). J Pediatr. 2001;139(5):715\u201323. \n                    https:\/\/doi.org\/10.1067\/mpd.2001.118534\n                    \n                  .","journal-title":"J Pediatr"},{"issue":"6","key":"579_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/MOP.0000000000000027","volume":"25","author":"AR Gennery","year":"2013","unstructured":"Gennery AR. Immunological features of 22q11 deletion syndrome. Curr Opin Pediatr. 2013;25(6):730\u20135. \n                    https:\/\/doi.org\/10.1097\/MOP.0000000000000027\n                    \n                  .","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"579_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1365-2249.1998.00629.x","volume":"113","author":"S Gupta","year":"1998","unstructured":"Gupta S, Aggarwal S, Nguyen T. Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly. Clin Exp Immunol. 1998;113(1):65\u201371.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"579_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2249.2000.01247.x","volume":"121","author":"M Pierdominici","year":"2000","unstructured":"Pierdominici M, Marziali M, Giovannetti A, Oliva A, Rosso R, Marino B, et al. T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol. 2000;121(1):127\u201332.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"579_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10024-002-2004-7","volume":"5","author":"H Zhou","year":"2002","unstructured":"Zhou H, Perkins SL, Tripp S, Hussong JW, Coffin CM. Expression of apoptosis-related antigens, Fas, bcl-2, and p53, and Mib-1 proliferation index in the hypoplastic thymus of DiGeorge syndrome. Pediatr Dev Pathol. 2002;5(5):465\u201371. \n                    https:\/\/doi.org\/10.1007\/s10024-002-2004-7\n                    \n                  .","journal-title":"Pediatr Dev Pathol"},{"key":"579_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1034\/j.1600-065X.2003.00047.x","volume":"193","author":"A Krueger","year":"2003","unstructured":"Krueger A, Fas SC, Baumann S, Krammer PH. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev. 2003;193:58\u201369.","journal-title":"Immunol Rev"},{"issue":"1","key":"579_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2008.01.002","volume":"66","author":"D Brenner","year":"2008","unstructured":"Brenner D, Krammer PH, Arnold R. Concepts of activated T cell death. Crit Rev Oncol Hematol. 2008;66(1):52\u201364. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2008.01.002\n                    \n                  .","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"579_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.cr.7290345","volume":"15","author":"N Zhang","year":"2005","unstructured":"Zhang N, Hartig H, Dzhagalov I, Draper D, He YW. The role of apoptosis in the development and function of T lymphocytes. Cell Res. 2005;15(10):749\u201369. \n                    https:\/\/doi.org\/10.1038\/sj.cr.7290345\n                    \n                  .","journal-title":"Cell Res"},{"issue":"1","key":"579_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaci.2011.03.042","volume":"128","author":"MA Fuente de la","year":"2011","unstructured":"de la Fuente MA, Recher M, Rider NL, Strauss KA, Morton DH, Adair M, et al. Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia. J Allergy Clin Immunol. 2011;128(1):139\u201346. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2011.03.042\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"579_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2015.12.016","volume":"71","author":"R Yazdani","year":"2016","unstructured":"Yazdani R, Fatholahi M, Ganjalikhani-Hakemi M, Abolhassani H, Azizi G, Hamid KM, et al. Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency. Mol Immunol. 2016;71:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.molimm.2015.12.016\n                    \n                  .","journal-title":"Mol Immunol"},{"key":"579_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10875-018-0523-x","volume":"38","author":"F Rieux-Laucat","year":"2018","unstructured":"Rieux-Laucat F, Magerus-Chatinet A, Neven B. The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions. J Clin Immunol. 2018;38:558\u201368. \n                    https:\/\/doi.org\/10.1007\/s10875-018-0523-x\n                    \n                  .","journal-title":"J Clin Immunol"},{"key":"579_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.0105-2896.2005.00261.x","volume":"205","author":"S Gupta","year":"2005","unstructured":"Gupta S. Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev. 2005;205:114\u201329. \n                    https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00261.x\n                    \n                  .","journal-title":"Immunol Rev"},{"issue":"2","key":"579_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0022-1759(97)00138-5","volume":"209","author":"H Lecoeur","year":"1997","unstructured":"Lecoeur H, Ledru E, Prevost MC, Gougeon ML. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods. 1997;209(2):111\u201323.","journal-title":"J Immunol Methods"},{"issue":"3","key":"579_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1148\/radiol.2273011499","volume":"227","author":"KH Zou","year":"2003","unstructured":"Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology. 2003;227(3):617\u201322. \n                    https:\/\/doi.org\/10.1148\/radiol.2273011499\n                    \n                  .","journal-title":"Radiology"},{"issue":"7","key":"579_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri2115","volume":"7","author":"PH Krammer","year":"2007","unstructured":"Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol. 2007;7(7):532\u201342. \n                    https:\/\/doi.org\/10.1038\/nri2115\n                    \n                  .","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"579_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","volume":"30","author":"A Strasser","year":"2009","unstructured":"Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity. 2009;30(2):180\u201392. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2009.01.001\n                    \n                  .","journal-title":"Immunity"},{"issue":"2","key":"579_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cellimm.2014.07.004","volume":"290","author":"X Li","year":"2014","unstructured":"Li X, Zhang Z, Peng A, He M, Xu J, Shen S, et al. Effect of CD95 on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Cell Immunol. 2014;290(2):209\u201316. \n                    https:\/\/doi.org\/10.1016\/j.cellimm.2014.07.004\n                    \n                  .","journal-title":"Cell Immunol"},{"issue":"1","key":"579_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1172\/JCI81217","volume":"126","author":"CA Klebanoff","year":"2016","unstructured":"Klebanoff CA, Scott CD, Leonardi AJ, Yamamoto TN, Cruz AC, Ouyang C, et al. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. J Clin Invest. 2016;126(1):318\u201334. \n                    https:\/\/doi.org\/10.1172\/JCI81217\n                    \n                  .","journal-title":"J Clin Invest"},{"issue":"1","key":"579_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0008-8749(02)00584-1","volume":"219","author":"K Arai","year":"2002","unstructured":"Arai K, Liu ZX, Lane T, Dennert G. IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell Immunol. 2002;219(1):48\u201356.","journal-title":"Cell Immunol"},{"issue":"3","key":"579_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1471-4159.2010.07124.x","volume":"116","author":"K Choi","year":"2011","unstructured":"Choi K, Ni L, Jonakait GM. Fas ligation and tumor necrosis factor alpha activation of murine astrocytes promote heat shock factor-1 activation and heat shock protein expression leading to chemokine induction and cell survival. J Neurochem. 2011;116(3):438\u201348. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07124.x\n                    \n                  .","journal-title":"J Neurochem"},{"issue":"3","key":"579_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/sji.12406","volume":"83","author":"DM Aresvik","year":"2016","unstructured":"Aresvik DM, Lima K, Overland T, Mollnes TE, Abrahamsen TG. Increased levels of interferon-inducible protein 10 (IP-10) in 22q11.2 deletion syndrome. Scand J Immunol. 2016;83(3):188\u201394. \n                    https:\/\/doi.org\/10.1111\/sji.12406\n                    \n                  .","journal-title":"Scand J Immunol"},{"issue":"2","key":"579_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0002-9149(98)00300-2","volume":"82","author":"T Toyozaki","year":"1998","unstructured":"Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F. Levels of soluble Fas ligand in myocarditis. Am J Cardiol. 1998;82(2):246\u20138.","journal-title":"Am J Cardiol"},{"issue":"10","key":"579_CR29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0002-9149(99)00133-2","volume":"83","author":"S Yamaguchi","year":"1999","unstructured":"Yamaguchi S, Yamaoka M, Okuyama M, Nitoube J, Fukui A, Shirakabe M, et al. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol. 1999;83(10):1500\u20133 A8.","journal-title":"Am J Cardiol"},{"issue":"4","key":"579_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0735-1097(01)01800-9","volume":"39","author":"M Shimizu","year":"2002","unstructured":"Shimizu M, Fukuo K, Nagata S, Suhara T, Okuro M, Fujii K, et al. Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris. J Am Coll Cardiol. 2002;39(4):585\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"579_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/CS20150624","volume":"130","author":"AC Huby","year":"2016","unstructured":"Huby AC, Turdi S, James J, Towbin JA, Purevjav E. FasL expression in cardiomyocytes activates the ERK1\/2 pathway, leading to dilated cardiomyopathy and advanced heart failure. Clin Sci (Lond). 2016;130(4):289\u201399. \n                    https:\/\/doi.org\/10.1042\/CS20150624\n                    \n                  .","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"579_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1055\/s-0032-1306418","volume":"21","author":"A Sahinarslan","year":"2012","unstructured":"Sahinarslan A, Boyaci B, Kocaman SA, Topal S, Ercin U, Okyay K, et al. The relationship of serum soluble Fas ligand (sFasL) level with the extent of coronary artery disease. Int J Angiol. 2012;21(1):29\u201334. \n                    https:\/\/doi.org\/10.1055\/s-0032-1306418\n                    \n                  .","journal-title":"Int J Angiol"},{"key":"579_CR33","doi-asserted-by":"publisher","unstructured":"Miyoshi T, Hosoda H, Nakai M, Nishimura K, Miyazato M, Kangawa K, et al. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias. Am J Obstet Gynecol. 2018. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2018.09.024\n                    \n                  .","DOI":"10.1016\/j.ajog.2018.09.024"},{"issue":"2","key":"579_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ydbio.2003.11.020","volume":"267","author":"D Sallee","year":"2004","unstructured":"Sallee D, Qiu Y, Liu J, Watanabe M, Fisher SA. Fas ligand gene transfer to the embryonic heart induces programmed cell death and outflow tract defects. Dev Biol. 2004;267(2):309\u201319. \n                    https:\/\/doi.org\/10.1016\/j.ydbio.2003.11.020\n                    \n                  .","journal-title":"Dev Biol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-018-0579-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0579-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T19:14:26Z","timestamp":1576696466000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-018-0579-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0579-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"assertion":[{"value":"13 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}